Nigel Pickett

Molomix Bioscience Limited (Molomix) is a pioneer in decentralised, innovative healthcare solutions designed to improve personalised care for all individuals. Our vision is to empower healthcare providers with affordable, accessible, innovative medical and genomic solutions. Our mission is to lead the transformation of healthcare by delivering cutting-edge diagnostic solutions that prioritise accessibility, affordability, and personalised care. Molomix connects global health technology innovators with governments and healthcare providers across the United Kingdom and Europe. A prime example is our partnership with SiGenex to introduce two key platforms: the first is a breakthrough technology for rapid genomic diagnostics; and the second simplifies and accelerates the analysis of molecular substances for critical applications like human, animal, and food-based pathogen detection. We use a data-driven, human-centred planning approach, allowing us to work with clinical and scientific research teams to identify those most at risk or who would benefit most from our services. This is matched with new and innovative technologies that are otherwise inaccessible, enabling our partners to deliver proactive care and achieve maximum impact for each patient's health and wellbeing.